North Star Asset Management Inc. lifted its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,455 shares of the semiconductor company’s stock after purchasing an additional 1,343 shares during the period. Synopsys makes up 1.3% of North Star Asset Management Inc.’s investment portfolio, making the stock its 23rd largest holding. North Star Asset Management Inc.’s holdings in Synopsys were worth $31,215,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Life Cycle Investment Partners Ltd acquired a new stake in shares of Synopsys in the fourth quarter valued at about $39,352,000. St. Louis Trust Co acquired a new stake in shares of Synopsys in the fourth quarter valued at about $1,449,000. Jefferies Financial Group Inc. acquired a new position in Synopsys during the fourth quarter worth about $314,000. Americana Partners LLC acquired a new position in Synopsys during the fourth quarter worth about $568,000. Finally, Axxcess Wealth Management LLC raised its position in Synopsys by 39.4% during the fourth quarter. Axxcess Wealth Management LLC now owns 4,581 shares of the semiconductor company’s stock worth $2,152,000 after acquiring an additional 1,295 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of SNPS opened at $524.74 on Friday. The company has a 50-day moving average of $451.00 and a two-hundred day moving average of $451.09. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The stock has a market cap of $100.52 billion, a P/E ratio of 81.48, a PEG ratio of 4.29 and a beta of 1.25. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of research reports. Piper Sandler cut their target price on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research report on Thursday, February 26th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research report on Friday, February 20th. Needham & Company LLC restated a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Morgan Stanley restated an “equal weight” rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Finally, Rosenblatt Securities cut their target price on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $536.00.
Check Out Our Latest Research Report on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
